Professional Documents
Culture Documents
discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/51437414
CITATION
READS
233
7 authors, including:
Alex Moroz
Steven R Edgley
University of Utah
11 PUBLICATIONS 10 CITATIONS
SEE PROFILE
SEE PROFILE
Henry L Lew
John Chae
SEE PROFILE
SEE PROFILE
Focused Review
INTRODUCTION
Parkinson disease (PD) is a common aging-related neurodegenerative disease. Its cause is
unknown; the pathophysiology has been explained by nigrostriatal pathway degeneration
associated with excessive accumulation of alpha-synuclein in specific areas of the brain [1].
The vulnerable areas include the locus ceruleus, hypothalamus, cranial nerve motor nuclei
and autonomic nervous system [1]. The mainstay of treatment is dopaminergic replacement
or enhancement. Despite the new agents that are continually being developed to augment
dopamine availability in neural tissue, as many as 50% of individuals with PD become
refractory to medical management beyond 5 years after initiation of treatment [2]. This
refraction manifests as the patient experiencing rapid motor fluctuations and/or dyskinesias
when on medication. Over the last 10 years, physiologic ablative procedures to effect deep
brain stimulation of specific nuclei of the basal ganglia (subthalamic, globus pallidus
internus) have become viewed as efficacious for up to 75% of appropriately selected
individuals who are considered medically refractory. The procedures are considered palliative, and their efficacy has been defined by stabilized function and improved quality of life
up to 5 years after surgery. For some individuals, this stabilization allows time to incorporate
exercise-based interventions as an adjunct to medical and surgical treatments. These
interventions can support functional stability before inevitable decline [3,4].
Several essential reviews of exercised-based interventions for persons with PD reported
favorable outcomes [5-8]. However, the literature is still evolving in that: (1) less than half
of the reviewed studies were randomized controlled trials; (2) about one-third of the
reviewed studies had sample sizes of fewer than 16 subjects; (3) more than half of the
reviewed studies discontinued their observations at the completion of the intervention
phases, not observing whether the positive effects of various interventions were sustained
over time. This present review provides an update of specific rehabilitation interventions in
PD supported by the literature.
S42
1934-1482/09/$36.00
Printed in U.S.A.
PM&R
S43
S44
Moroz et al
Definition
Alexander
Technique
Tui-na
Qigong
PM&R
S45
S46
Moroz et al
CAREGIVER TRAINING
REFERENCES
1. Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinsons
disease. Ann Rev Neurosci 1999;22:123-144.
2. Drugs for Parkinsons disease. Treatment guidelines. Med Letter
2007;5:89-94.
3. Deuschl G, Wenzelburger R, Kopper F, et al. Deep brain stimulation
for the treatment of Parkinsons disease: a therapy approaching evidenced-based standards. J Neurol 2002 Suppl:S43-S46.
4. Volkmann J. Deep brain stimulation for the treatment of Parkinsons
disease. J Clin Neurophysiol 2004;21:6-17.
5. Gage H, Storey L. Rehabilitation for Parkinsons disease: a systematic
review of available evidence. Clin Rehabil 2004;18:463-482.
6. Crizzle AM, Newhouse IJ. Is physical exercise beneficial for persons
with Parkinsons disease? Clin J Sport Med 2006; 16(5):422-425.
7. Movement Disorder Society. Physical and occupational therapy in
Parkinson disease. Move Disord 2002 (Suppl 4);17:S156-159.
8. Deane KHO, Ellis-Hill C, Jones D, et al. Systemic review of
paramedical therapies for Parkinsons disease. Move Disord 2002;
17: 984-991.
9. Sunvisson H, Ekman SL, Hagberg H, Lkk J. An education programme for individuals with Parkinsons disease. Scand J Caring Sci
2001;15(4):311-317.
10. Trend P, Kaye J, Gage H, et al. Short-term effectiveness of intensive
multidisciplinary rehabilitation for people with Parkinsons disease
and their careers. Clin Rehabil 2002;16:717-725.
11. Wade DT, Gage H, Owen C, et al. Multidisciplinary rehabilitation for
people with Parkinsons disease: a randomized controlled study.
J Neurol Neurosurg Psychiatry 2003;74:158-162.
12. Playford ED. Multidisciplinary rehabilitation for people with Parkinsons disease. JNeurol Neurosurg Psychiatry 2003;74:148-149.
13. Nieuwboer A, DeWeerdt W, Dom R, et al. Prediction of outcome of
physiotherapy in advanced Parkinsons disease. Clin Rehabil 2002;
16:886-893.
14. Deane KHO, Jones D, Ellis-Hill C, et al. Physiotherapy for Parkinsons
disease: a comparison of techniques (Review). Cochrane Database
Syst Rev 2001; (1)CD002815. doi:10.1002/14651858.CD002815.
15. Cees JT, deGoede PT, Samyra HJ, et al. The effects of physical therapy
on Parkinsons disease: a research synthesis. Arch Phys Med Rehabil
2001;82:509-515.
*16. Keus SHJ, Bloem BR, Hendriks EJM, et al. Evidence-based analysis of
physical therapy in Parkinsons disease with recommendations for
practice and research. Move Disord 2007;22:451-460.
*17. Rubinstein TC, Giladi N, Hausdorff JM. The power of cueing to
circumvent dopamine deficits: a review of physical therapy treatment
of gait disturbances in Parkinsons disease. Move Disord 2002;17:
1148-1160.
18. Stolze H, Kuhtz-Buschbeck JP, Drucke H, et al. Comparative analysis
of the gait disorder of normal pressure hydrocephalus and Parkinsons disease. J Neurol Neurosurg Psychiatry 2001;70:289-297.
19. Ziv I, Avraham M, Dabby R, et al. Early occurrence of manual motor
blocks in Parkinsons disease: a quantitative assessment. Acta Neurologia Scand 1999;99:106-111.
PM&R
S47
42. Pohl M, Rockstroh G, Ruckriem S, et al. Immediate effects of speeddependent treadmill training on gait parameters in early Parkinsons
disease. Arch Phys Med Rehabil 2003;84:1760-1766.
43. Dibble LE, Hale TF, Marcus RL, et al. High-intensity resistance
training amplifies muscle hypertrophy and functional gains in persons with Parkinsons disease. Move Disord 2006;21(9):1444-1452.
44. Dibble LE, Hale TF, Marcus RL, et al. The safety and feasibility of
high-force eccentric resistance exercise in persons with Parkinsons
disease. Arch Phys Med Rehabil 2006;87(9)1280-1282.
45. Tamir R, Dickstein R, Huberman M. Integration of motor imagery and
physical practice in group treatment applied to subjects with Parkinsons disease. Neurorehabil Neural Repair 2007;21(1):68-75.
*46. Bloem, BR, Hausdorff, JM, Visser, JE, et al. Falls and freezing of gait in
Parkinsons disease: a review of two interconnected, episodic phenomena. Move Disord 2004;19:871-884.
47. Giladi, N, McDermott, MP, Fahn, S, et al. Freezing of gait in PD:
prospective assessment in the DATATOP cohort. Neurology 2001;56:
1712-1721.
48. Cubo E, Moore CG, Leurgans S, et al. Wheeled and standard walkers
in Parkinsons disease patients with gait freezing. Parkinsonism Rel
Disord 2003;10:9-14.
49. Kompoliti K, Goetz CG, Leugans S, et al. On freezing in Parkinsons
disease: resistance to visual cue walking devices. Move Disord 2000;
15:309-312.
50. Viliani T, Pasquetti P, Magnolfi S, et al. Effects of physical training on
straightening-up processes in patients with Parkinsons disease. Disabil Rehabil 1999;21:68-73.
51. Toole T, Hirsch MA, Forkink A, et al. The effects of a balance and
strength training program on equilibrium in parkinsonism: a preliminary study. NeuroRehabilitation 2000;14:165-174.
*52. Hirsch MA, Toole T, Maitland CG, et al. The effects of balance training
and high resistance training on persons with idiopathic Parkinsons
disease. Arch Phys Med Rehabil 2003;84:1109-1117.
53. Jobges M, Heuschkel G, Pretzel C, et al. Repetitive training of compensatory steps: a therapeutic approach for postural instability in
Parkinsons disease. J Neurol Neurosurg Psychiatry 2004;75:16821687.
54. Stankovic I. The effect of physical therapy on balance of patients with
Parkinsons disease. Int J Rehabil Res 2004;27;53-57.
55. Niewboer A, Kwakkel G, Rochester L, et al. Cueing training in the
home improves gait-related mobility in Parkinsons disease: the Rescue trial. J Neurol Neurosurg Psychiatry 2007;78(2):134-140.
56. Rajendran PR, Thompson RE, Reich SG. The use of alternative therapies by patients with Parkinsons disease. Neurology 2001;57:790794.
57. Brefel-Courbon C, Desboeuf K, Thalamas C, et al. Clinical and
economic analysis of spa therapy in Parkinsons disease. Move Disord
2003;18:578-584.
58. Stallibrass C, Sissons P, Chalmers C. Randomized controlled trial of
the Alexander Technique for idiopathic Parkinsons disease. Clin
Rehabil 2002;16:695-708.
59. Svircev A, Craig LH, Juncos JL. A pilot study examining the effects of
neuromuscular therapy on patients with Parkinsons disease. J Am
Osteopath Assoc 2005;105:26.
60. Craig LH, Svircev A, Haber M, et al. Controlled pilot study of the
effects of neuromuscular therapy in patients with Parkinsons disease.
Move Disord 2006;21(12):2127-2133.
61. Eng ML, Lyons KE, Greene MS, et al. Open-label trial regarding the
use of acupuncture and yin tui na in Parkinsons disease outpatients:
a pilot study on efficacy, tolerability, and quality of life. J Alternat
Complement Med 2006;12(4):395-399.
62. Burini D, Farabollini B, Iacucci S, et al. A randomized controlled
cross-over trial of aerobic training versus Qigong in advanced Parkinsons disease. Europa Medicophysica 2006;42(3):231-238.
63. Hass CJ, Collins MA, Juncos JL. Resistance training with creatine
monohydrate improves upper body strength in patients with Parkinson disease: a randomized trial. Neurorehabil Neural Rep 2007;
21(2):107-115.
S48
Moroz et al
*64. Murphy S, Tickle-Degnen L. The effectiveness of occupational therapy-related treatments for persons with Parkinsons disease: a metaanalytic review. Am J Occupat Ther 2001;55:385-392.
65. Platz T, Brown RG, Marsden CD. Training improves the speed of
aimed movements in Parkinsons disease. Brain 1998;121:505-514.
66. Rogers MA, Phillips JG, Bradshaw JL, et al. Provision of external cues
and movement sequencing in Parkinsons disease. Motor Control
1998; 2:125-132.
67. Meschak RP, Norman KE. A randomized controlled trial of the effects
of weights on amplitude and frequency of postural hand tremor in
people with Parkinsons disease. Clin Rehabil 2002;16:481-492.
68. Albani G, Pignatti R, Bertella L, et al. Common daily activities in the
virtual environment: a virtual study in parkinsonian patients. Neurologl Sci 2002;23(Suppl):S49-S50.
69. Schulz GM. The effects of speech therapy and pharmacologic treatments on voice and speech in Parkinsons disease: a review of the
literature. Current Medicinal Chem 2002;9:1359-1366.
70. Movement Disorder Society. Speech therapy in Parkinsons disease.
Move Disord 2002;17 (Suppl 4):S163-166.
71. Deane KHO, Whurr R, Playford ED, et al. Speech and language
therapy for dysarthria in Parkinsons disease: a comparison of techniques (review). Cochrane Database Syst Rev 2001;(2):CD0022814.
doi:10.1002/14651858.CD002814.
*72. Ramig LO, Sapir S, Countryman S, et al. Intensive voice treatment
(LSVT) for patients with Parkinsons disease: a 2-year follow up.
J Neurol Neurosurg Psychiatry 2001;71:493-498.
73. Ramig LO, Fox C, Sapir W. Parkinsons disease: speech and voice
disorders and their treatment with Lee Silverman Voice Treatment.
Sem Speech Lang 2004;25:169-180.
74. Baumgartner CA, Sapir S, Ramig LO. Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus re-
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.